Peptide generation by the UPS (ubiquitin-proteasome system) is rate-limiting in MHC class I-restricted antigen presentation in response to virus-induced IFNs (interferons). In this process, the role of IFN-induced rapid remodelling of the UPS is less defined. IFN-mediated de novo formation of different proteasome compositions as i20S (immunoproteasomes) or m20S (mixed-type proteasomes) essentially supports the rapid adjustment of the mammalian immune system to pathogens. This adjustment is of particular importance for the immune response to rapidly replicating viruses. In agreement, i20S formation has been shown to be an accelerated and transient response. Moreover, i20S and/or PA28 (proteasome activator 28) are essentially required for the generation of certain viral epitopes. In the present paper, we discuss how IFNs consecutively regulate the UPS at different levels, thereby improving the immune responsiveness of target cells.
The UPS (ubiquitin-proteasome system)
Conjugation of proteins with ubiquitin modifiers or UBLs (ubiquitin-like proteins) represents a post-translational modification signal involved in the regulation of a variety of cellular responses [1] . Depending on the kind of ubiquitination, different pathways can be utilized: polyubiquitin chains at substrates serve as a signal for their selective degradation by the proteasome. On the other hand, mono-ubiquitination of protein targets is involved in signalling or endocytosis [2] . Thus the UPS controls intracellular protein homoeostasis and quality and the availability of regulator proteins and it generates antigenic peptides for the recognition of viral or tumorigenic transformed target cells by CTL (cytotoxic T-lymphocyte) [1, [3] [4] [5] .
Protein substrates become tagged with ubiquitin or UBLs in an ATP-dependent manner by a three-step process involving the sequential action of the ubiquitin-activating enzyme E1, several cognate E2 ubiquitin-conjugating enzymes and a series of substrate-specific E3 ubiquitin ligases that physically interact with the substrate to transfer ubiquitin moieties. Multiple DUBs (deubiquitinating enzymes) can counteract this process and remove the ubiquitin or UBL tag [1, 3, 4] . In this context, it is important to note that more than 1000 components related to the mammalian UPS have so far been identified to be involved in ubiquitin conjugation, deconjugation, substrate recognition and degradation. In addition to more than 40 different subunits of the proteasome, the human genome encodes 15 E1-isoforms that can activate ubiquitin or ten other UBLs. Moreover, 77 family members of the E2 enzymes and more than 600 monomeric E3 ligases or components of multimeric E3 ligases have been recognized [4] . Furthermore, there exist various proteins containing ubiquitin domains, proteins with ubiquitin interaction domains that often serve as adaptors and more than 90 DUBs [4] .
Polyubiquitinated substrates are degraded by the 26S proteasome consisting of the catalytic 20S core complex capped by one or two 19S regulatory particles [5] . The 20S particles comprise four staggered rings, each containing seven nonidentical subunits. The outer rings contain the α-subunits (α1-α7), which form the 'gates' through which substrates enter and products are released. In addition to the 19S regulatory complex, the PA28 (proteasome activator 28) can interact with the α-ring of the 20S complex, which opens the gates and may support the generation of antigenic peptides [6] . Each of the two inner rings contain the β-subunits (β1-β7), three of which (β1, β2 and β5) harbour the six active sites [7, 8] . In addition, specific catalytically active proteasome subunits referred to as immunosubunits [9] are incorporated into alternative proteasome compositions and improve antigen processing [10] [11] [12] .
Thus there exist at least two types of proteasomes, namely s20S (standard proteasomes) that are constitutively expressed in all cells and i20S (immunoproteasomes) that are formed on exposure of cells to IFNs (interferons). Additionally, the so-called intermediate proteasomes or m20S (mixed-type proteasomes) were found in different tissues that contain constitutive as well as immunosubunits and have been shown to be enzymatically active [13, 14] . After expression of all subunits and helpers, α-ring assembly is facilitated in the cytoplasm and targeted to the ER by interaction with POMP. POMP mediates ER binding, recruits the remaining β-subunits into the nascent complex and supports final proteasome maturation. Thereby POMP is degraded by the newly formed 20S proteasome. Assembly of i20S and m20S basically follows the same principle after the coincident induction of POMP and the immunosubunits β1i, β2i and β5i by an immunological challenge.
programme involving the biosynthesis of all subunits, their assembly and maturation processes [15] . Thus proteasomal activities are controlled at the level of subunit expression, subunit incorporation and the maturation dynamics of the active sites.
After biosynthesis of all subunits, current assembly models for eukaryotic 20S proteasomes assume that the initial assembly step is the formation of a heptameric α-ring serving as a matrix for the subsequent incorporation of β-subunits [15] . Active-site β-subunits are incorporated as proproteins that essentially mature by an autocatalytic, two-step procedure within the precursor complexes. The removal of the β-subunit-propeptides liberates the active-site threonine residues of the now active 20S core proteasome [15] [16] [17] [18] . Co-ordinated assembly of proteasomes requires helper factor as the mammalian POMP (proteasome maturation protein), which facilitates the recruitment and co-ordinate processing of the β-subunits, thereby becoming the first substrate of the activated 20S proteasome. Thus degradation of POMP signals the successful completion of the biogenesis programme [19] . Incorporation and maturation dynamics of active-site β-subunits are strictly determined by their propeptides [19] [20] [21] [22] . This phenomenon becomes especially apparent in human cancer cells expressing the non-functional immunosubunit variant LMP7E1 (low-molecular-mass protein 7E1) bearing an alternative propeptide. The molecular explanation for this phenomenon is the incapacity of LMP7E1 to interact with POMP, which results in i20S deficiency [23] .
Major steps in the formation of c20S and i20S take place at the ER (endoplasmic reticulum) surface by a POMP-mediated mechanism. Thereby POMP interacts with ER membranes, binds α 1−7 rings, recruits β-subunits and mediates the association of POMP-containing precursor complexes with the ER. This ER-associated proteasome formation can ensure a sufficient supply of newly formed proteasomes to fulfil its roles in ER-associated protein degradation and generation of antigenic peptides, which are transported into the ER [24] (Figure 1) .
It is well known that type II IFNs (IFN-γ ) induce the synthesis of the so-called immunosubunits, β1i/LMP2, β2i/MECL1 (multicatalytic endopeptidase complex-like 1) and β5i/LMP7, which are co-operatively incorporated into nascent proteasomes, thereby replacing their constitutive homologues β1, β2 and β5 [16, 18, 25] . Immunosubunits together with other components of the APM (antigen presentation machinery) can also be induced rapidly by type I IFNs (IFN-α and -β) prior to IFN-γ action [26] [27] [28] . IFN-α and -β are a family of secreted cytokines induced as a very early response to viral infection of eukaryotic cells. Whereas almost all cell types secrete type I IFNs at low levels, haemopoietic cells are the major source of IFN-α and fibroblasts are major producers of IFN-β. Type I IFNs exhibit both autocrine and paracrine effects by stimulation of neighbouring cells and recruitment of NK cells (natural killer cells) to produce IFN-γ during the first day after infection [29, 30] . As a result of the fast IFN secretion, immunosubunits are rapidly induced and incorporated into nascent proteasomes.
Interestingly, IFN-γ also enhanced POMP mRNA levels, suggesting that POMP may play an important role in i20S biogenesis [19] . Investigation of the kinetics, the molecular role of POMP, β5i/LMP7 and proteasome turnover in this proteasomal immune adaptation revealed answers to the question of how cells regulate proteasome levels in response to IFNs. Taking POMP turnover as a signal for completion of biogenesis, i20S are formed 4-fold faster than s20S. This high turnover of POMP is strictly dependent on the induction of a functional β5i/LMP7. Both components, POMP and β5i/LMP7, are essential for the rapid up-regulation of i20S formation by physical interaction. Silencing of POMP by RNA interference resulted in accumulation of ubiquitinated proteasomal substrates, reduced MHC I surface expression and ultimately cell death [22] . In combination with the observed drastically reduced half-life of i20S compared with s20S, our experiments explain that proteasomal immune adaptation is a highly dynamic and transient response [22] .
In tissues and organs, the formation of different proteasome species is consistently more complex, since IFNs also induce the formation of m20S complexes. Even in lymphatic cells the i20S content does not exceed a critical limit of 60 % of the total proteasome content [31, 32] . Thus a varying mixture of different proteasome compositions seems to constitute the cellular proteasome pool depending on environmental requirements. In addition to type I IFNs, i20S formation in human target cells can also be induced by infection with HCV (hepatitis C virus), which cannot be further increased by IFNγ release in vivo [27, 28] . Soon after an immunological challenge, when 20S complexes are formed de novo, the cellular proteasome population is remodelled in its subtypes and also in its functional properties. Thus this mechanism has a direct impact on the resulting immune response [31, 32] . In detail, i20S serves a dual role in infected and non-infected cells. Secretion of IFNs in response to infection results in a fast i20S formation, which maintains protein homoeostasis and generates pathogen-derived epitopes in parallel. Thereby such cells are labelled as target cells for destruction by specific CTLs. In contrast, in non-infected cells, i20S are especially responsible for the preservation of intracellular protein balance. Thus proteasomal immune adaptation is rapid enough to contribute to an efficient immune response and permits the fast return to the constitutive situation once i20S function is not required any more. This mechanism is especially important in infected tissues to reduce massive cellular damage of surrounding tissue (Figure 2 ).
In conclusion, the formation pathway of different proteasome types constitutes an important cellular control mechanism for the quality and quantity of proteasomemediated protein degradation and/or antigen presentation in both the regulatory as well as the scavenger sense.
The role of the UPS in response to IFNs and infections
MHC class I-restricted antigen presentation is an essential step in the priming of CD8 + T-lymphocytes by professional antigen-presenting cells as well as for the elimination of infected target cells by CTLs during immune responses to infection. The kinetics of in vivo priming of CD8 + T-cells by antigen presentation turned out to be surprisingly rapid and transient, since pathogen-specific T-lymphocytes were programmed during the first 24 h and the priming capacity lasted only 72 h in a Listeria infection model [33] .
Peptide generation by the UPS is rate-limiting in MHC class I-restricted antigen presentation [34] . Thus the UPS is an essential component of an efficient immune system. In order to conserve the balance of protein synthesis and turnover, freshly translated polypeptides and short-lived proteins represent a main source of proteasomal substrates [35, 36] . An increasing number of reports indicate that defined antigenic peptides derive from such freshly translated polypeptides. These peptides are assumed to be generated by a subset of ribosomes, the so-called 'immunoribosomes' in response to infections, and are further degraded by proteasomes after ubiquitination [37] . This is especially important during viral infections as many viruses can replicate rapidly and high amounts of antigenic peptides have to be generated from viral proteins in very short times, which results in a rapid CTL response [38] . Viral infections can induce also an increased generation of defective ribosomal products by manipulation of the host cell translational machinery, which additionally contributes to an enhanced MHC class I loading. In this context, modifications of the translation efficiency have been observed in cells infected with Semliki Forest virus and in target cells expressing a truncated EBV (Epstein-Barr virus)-encoded nuclear antigen 1 protein [39, 40] . A regulated activity of translation also seems to be crucial during dendritic cell maturation and is in line with MHC class I-restricted antigen presentation derived from newly synthesized proteins [41] .
The connection of the UPS to antigen presentation
Efficient elimination of virus-infected target cells by CTLs can only occur by a rapid MHC class I antigen presentation of viral epitopes on the cell surface. To cope with rapidly replicating viruses without delay, the immune system of a challenged organism requires the timely formation and availability of i20S. All known data indicate that IFNmediated induction of i20S can improve MHC class I antigen presentation by more efficient production of certain viral peptides [5, 12, 15] . The most drastic effects have been described for the generation of the epitope of the hepatitis B virus core antigen [42] and the influenza A matrix protein M1 ( [43] and S. Urban, E. Krüger and U. Seifert, unpublished work), which are completely dependent on i20S. An important role for i20S could also be observed when we analysed the generation of an epitope (HCV-NS3 1073−1081 ) derived from the HCV-NS3 protein.
Comparison of the NS3 987−1133 sequence derived from an infectious source with sequences that we isolated from sera of persistently infected patients revealed a high mutation rate at NS3
1082 . This position is located directly adjacent to the epitope's C-terminus and affects proteasomal processing negatively. i20S appeared to digest the wild-type polypeptide more rapidly than the c20S, resulting in a more efficient epitope generation [44] . The importance of the rapid i20S formation was also analysed by generation of antigenic peptides derived from Listeria monocytogenes in mice lacking the immunosubunits β5i/LMP7 and β2i/MECL1. Besides the inability of i20S-deficient mice to generate CTLs against the epitope E1B 192−200 , it turned out to be important and ratelimiting that antigen processing occurs early during infection [45] . Moreover, formation of i20S is especially important for the determination of MHC class I epitope hierarchy [46] .
Direct evidence that the composition of 20S particles is more complex in living cells or organisms and has an impact on epitope generation derives from experiments with cells and mice expressing different m20S compositions. It has been observed that the generation of the melanoma epitope (MART 26−35 , where MART is melanoma antigen recognized by T-cells) was impaired by complete i20S, whereas epitope generation was sufficient in β1i/LMP2-knockout mice only containing β5i/LMP7 m20S ( [47] and M. Keller, E. Krüger and U. Seifert, unpublished work). Concomitant with i20S, other components of the APM, such as PA28, are up-regulated by IFN-γ [5, 12, 15] . It was proposed that PA28 might allow the release of slightly longer peptides supporting MHC class I antigen presentation. The influence of PA28 on epitope processing turned out to differ when various epitopes were analysed. Besides the tumour/self-epitope TRP2 360−368 (TRP2 is tyrosinase-related protein 2), whose generation is entirely dependent on PA28, there also exist several other examples of epitopes whose generation is improved by PA28 [15, 48, 49] .
Although antigen presentation on infected target cells is an essential prerequisite for rapid recognition and elimination by primed and differentiated CTLs, the dynamics of this process in target cells is still poorly defined. Therefore we have determined the induction kinetics of the immunosubunits and PA28α/β in response to IFNα and IFNγ after 2, 4 and 6 h. It turned out that mRNA expression of all three immunosubunits is induced already after 4 h. To extend our study to other components of the UPS, we investigated the expression of genes related to the UPS in response to type I and type II IFNs in an UPS-focused microarray analysis. Using HeLa cells treated either with IFNγ or IFNα in a time course experiment, it turned out that both IFNγ and IFNα induced more than 20 E3 ligases. These experiments together with the induction of the APM including the i20S subunits and PA28αβ resulted in an unforeseen picture of how IFNs consecutively remodel the UPS at different levels. Thereby the immune responsiveness of target cells is largely improved. The molecular mechanisms of this immune adaptation of the UPS in target cells in these early stages up to 24 h after an immunological challenge remain however to be determined in more detail.
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